![Colin Broom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Broom
Directeur Général chez
Pulmotect, Inc.
Profil
Colin Broom is currently the Chief Executive Officer & Director at Pulmotect, Inc. He is also a Member of The Royal College of Physicians and a Member of the Faculty of Pharmaceutical Medicine.
Previously, he served as the Chief Executive Officer at Nabriva Therapeutics GmbH from 2014 to 2017.
He was an Independent Director at NPS Pharmaceuticals, Inc. from 2009 to 2015.
Dr. Broom also served as a Director at Nabriva Therapeutics Plc from 2014 to 2023.
He held the position of VP-European Clinical Development & Medical Affairs at Amgen, Inc. from 2000 to 2003.
From 2004 to 2014, he was the Chief Scientific Officer & Vice President at Shire ViroPharma, Inc. He was the Senior Vice President-Global Clinical Development at Hoechst Marion Roussel, Inc. in 1999.
Dr. Broom started his career as a Vice President at The Gi Co., Inc. from 1987 to 1998.
He completed his undergraduate studies at University College London and obtained a doctorate degree from St. George's University of London.
Postes actifs de Colin Broom
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Directeur Général | 30/09/2019 |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Colin Broom
| Sociétés | Poste | Fin |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Directeur Général | 24/07/2018 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Directeur Général | 23/06/2017 |
| NPS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Directeur Technique/Scientifique/R&D | 01/01/2014 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2003 |
Formation de Colin Broom
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faculty of Pharmaceutical Medicine | |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
The Gi Co., Inc.
 The Gi Co., Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat gastrointestinal and related diseases | Health Technology |
St. George's University of London
 St. George's University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Choisissez Zonebourse 
